Description: In this session, the presenters will discuss (1) results from a recent study of credibility applications in the pricing of group long term disability business, (2) morbidity experience from individual disability business, and (3) lessons can be learned from each line of business.

Description: As baby boomers continue aging into Medicare, prescription drug plans (PDPs) will continue to be an option to meet prescription drug needs. Several new PDPs introduced in 2019 address these needs, and we will share our experiences with implementing, pricing and operationalizing a new PDP, including how this product integrates across the enterprise. While we will discuss topics specific to launching a PDP, several of the concepts can be generalized to starting other insurance product lines within an organization.

Description: The National Academy of Social Insurance (the Academy) recently released a comprehensive study on models for states interested in pursuing social insurance initiatives for LTSS, paid leave and child care reform. The report explores strategies that states could pursue to better support families in meeting evolving care needs over the lifespan. Actuarial projections for illustrative policy options are included. The presenters will report back the Academy study panel's findings, provide in-depth insights into Washington State's new long-term care social insurance program, and briefly report on other state activity in the LTSS and paid leave domains.

Description: To some degree, we all operate in an environment influenced by regulation and accounting standards. This session builds on the first session in this series by considering how regulators are reacting to the biometric influencers, then delving into the impact of changing accounting standards on how firms assess, value and report on their business. Consideration will be given to uncertainties around pending regulation, including those uncovered in the process of firms implementing Principles Based Reserving and those yet to come with modifications to GAAP. This session is for anyone interested in better understanding the impact and influence that regulatory and reporting uncertainty has on their work.

Description: As value-based solutions evolve, it is more important than ever for providers to understand their performance and how it is measured, along with the drivers of success. Presenters will cover the evolution of past risk-transfer programs such as Medicare Shared Savings Program and Next Generation ACO. They will also discuss the new Primary Care First and Direct Contracting models recently announced by CMS.

Description: Administration system updates and conversions. Legacy systems and their associated problems. Continued low interest rates and in-force policy management actions affecting policyholder behavior. These are but a few of the taxation challenges facing insurers managing the growing complexity of their businesses.<p> Presenters will consider these and other product taxation-related issues, highlighting ways insurers have sought to address them, their impacts, and potential mitigation strategies

Description: The presenters focus on traditional and non-traditional techniques for setting IBNR and assume some experience on the topic. Take in a brief overview of the basic development of IBNRs for financial reporting. Then explore general considerations and various methods used to estimate claim costs, plus understand variability in IBNR projections as well as challenges that arise in certain situations. There will be opportunities for the audience to share ideas and considerations based on past experiences.

Description: While most actuaries work for companies and have as a primary objective the financial success of their employers, regulatory actuaries primarily serve the public interest. In part one of this presentation, we will explore the role of actuaries whose priority is to serve the public interest. Regulation is developed by a deliberative process that includes regulators, the American Academy of Actuaries, trade associations and the companies that will be affected by the regulation. In part two of this session, we will present a series of vignettes each focusing on recent updates to the Valuation Manual. At the conclusion of the session, attendees will have a deeper appreciation of what goes on behind the scenes in the development of regulation.

Description: In this session, senior pension and insurance investment professionals will share their thoughts on current investment topics. Attendees will hear about leading edge investment ideas and practices from industry leaders.

Description: In this session, morbidity and life expectancy trends are discussed. In addition, a case study in R on how to model the uncertainty associated with incidence of disability, disabled and active deaths and other terminations is presented.